Microbiome Therapeutics Whitespace Analysis Market is Segmented By Therapeutic Area (Gastrointestinal Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Others), By Modality (Probiotics, Fecal Microbiota Transplantation (FMT), Postbiotics, Live Biotherapeutic Products, Synthetic Microbial Communities), By Stage of Development (Large-scale Manufacturing, Small-scale/Specialty Manufacturing), By End User (Preclinical, Phase 1, Phase 2, Phase 3, Approved/Marketed), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa). The report offers the value (in USD Million) for the above-mentioned segments.